EUVIMEDEUVIMED entdecken
Open Access

Characterizing the transmembrane domains of ADAM10 and BACE1 and the impact of membrane composition

Conor B Abraham, Lin Xu, George A Pantelopulos, John E Straub

Biophysical Journal · 2023

DOI: 10.1016/j.bpj.2023.08.025 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biophysical Journal, 2023. Verfasst von Conor B Abraham und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, Boston University, Boston, Massachusetts. Hauptthemen laut MEDLINE: Amyloid Precursor Protein Secretases, Alzheimer Disease. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 68 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIGMS NIH HHS, National Institutes of Health, National Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The β-secretase, BACE1, and the α-secretase, ADAM10, are known to competitively cleave amyloid precursor protein (APP) in the amyloid cascades of Alzheimer's disease. Cleavage of APP by BACE1 produces a 99-residue C-terminal peptide (APP-C99) that is subsequently cleaved by γ-secretase to form amyloid-β (Aβ) protein, whereas cleavage of APP by ADAM10 is nonamyloidogenic. It has been speculated that ADAM10/APP and BACE1/APP interactions are regulated by colocalization within and outside of liquid-ordered membrane domains; however, the mechanism of this regulation and the character of the proteins' transmembrane domains are not well understood. In this work, we have developed and characterized minimal congener sequences for the transmembrane domains of ADAM10 and BACE1 using a multiscale modeling approach combining both temperature replica exchange and conventional molecular dynamics simulations based on the coarse-grained Martini2.2 and all-atom CHARMM36 force fields. Our results show that membrane composition impacts the character of the transmembrane domains of BACE1 and ADAM10, adding credence to the speculation that membrane domains are involved in the etiology of Alzheimer's disease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Amyloid Precursor Protein SecretasesAlzheimer DiseaseHumansMembrane ProteinsAspartic Acid EndopeptidasesAmyloid beta-Protein PrecursorADAM10 ProteinAmyloid beta-Peptides

Substanzen

Amyloid Precursor Protein SecretasesMembrane ProteinsAspartic Acid EndopeptidasesAmyloid beta-Protein PrecursorADAM10 ProteinAmyloid beta-PeptidesADAM10 protein, humanBACE1 protein, human

Autor:innen und Institutionen

  • Department of Chemistry, Boston University, Boston, Massachusetts.
  • Department of Chemistry, Boston University, Boston, Massachusetts; Laboratory of Chemical Physics, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland.
  • Department of Chemistry, Boston University, Boston, Massachusetts. Electronic address: straub@bu.edu.

Förderung

  • NIGMS NIH HHS
  • National Institutes of Health
  • National Science Foundation

Zitieren

APA

Abraham, C. B., Xu, L., Pantelopulos, G. A., & Straub, J. E. (2023). Characterizing the transmembrane domains of ADAM10 and BACE1 and the impact of membrane composition. Biophysical Journal. https://doi.org/10.1016/j.bpj.2023.08.025

Vancouver

Abraham CB, Xu L, Pantelopulos GA, Straub JE. Characterizing the transmembrane domains of ADAM10 and BACE1 and the impact of membrane composition. Biophysical Journal. 2023. doi:10.1016/j.bpj.2023.08.025

BibTeX
@article{Abraham2023,
  author = {Abraham, Conor B and Xu, Lin and Pantelopulos, George A and Straub, John E},
  title = {Characterizing the transmembrane domains of ADAM10 and BACE1 and the impact of membrane composition},
  journal = {Biophysical Journal},
  year = {2023},
  doi = {10.1016/j.bpj.2023.08.025}
}
Kostenlos starten →